Giant Cell Arteritis

When Is Rheum Discussion Reasonable for Giant Cell Arteritis?

A concise clinician-facing triage reference for GCA concern, vision symptoms, jaw claudication, temporal headache, Ophtho pathway, and biopsy/imaging timing.

Educational onlyDraft last updated June 12, 2026

Quick answer

Giant Cell Arteritis Triage

Rheum discussion is reasonable when

Higher-Yield Consult Context

Rheum discussion is reasonable when GCA concern includes vision symptoms, jaw claudication, new temporal headache, scalp tenderness, PMR features, or local vision-emergency trigger.

Workup or another service usually comes first when

Better First Step

Local emergency, Ophtho, stroke/Neuro, and vision pathways may be first or concurrent when vision threat or neurologic symptoms are present.

Before You Consult

What to Include

Include symptom timing, vision findings, jaw claudication, scalp tenderness, temporal artery findings, ESR/CRP, steroids already given/planned, Ophtho pathway, and biopsy/imaging plan.

Better consult question

Ask the Decision, Not Just the Diagnosis

Can Rheum help with ***? Current facts are ***. The local pathway or service already active is ***. The decision we need is ***.

Common pitfall

Low-Yield Framing

A low-yield message names the problem without the first-step data, local pathway status, or disposition-changing question.

FAQ

Clinician Questions

What is the fastest way to make this consult answerable?

State the clinical question, first steps already completed, relevant labs/imaging/exam findings, and the decision Rheum can change.

When should another pathway move first?

When local emergency, airway, trauma, surgery, ICU, infection, source-control, or procedural pathway applies, activate that pathway while specialty discussion proceeds as needed.

References

Educational tool only. SIC provides clinician-facing educational consult-triage references. SIC does not diagnose, treat, prevent, cure, or mitigate disease and is not a substitute for clinical judgment, local guidelines, institutional referral pathways, or recommendations from your rheumatology department. See disclaimer and how SIC works.